Afatinib in paediatric patients with recurrent/refractory ErbB-dysregulated tumours: Results of a phase I/expansion trial.
Saved in:
| Title: | Afatinib in paediatric patients with recurrent/refractory ErbB-dysregulated tumours: Results of a phase I/expansion trial. |
|---|---|
| Authors: | Geoerger, Birgit1 (AUTHOR) birgit.geoerger@gustaveroussy.fr, Marshall, Lynley V.2 (AUTHOR), Nysom, Karsten3 (AUTHOR), Makin, Guy4,5 (AUTHOR), Bouffet, Eric6 (AUTHOR), Defachelles, Anne-Sophie7 (AUTHOR), Amoroso, Loredana8 (AUTHOR), Aerts, Isabelle9 (AUTHOR), Leblond, Pierre10 (AUTHOR), Barahona, Paulette11 (AUTHOR), Van-Vlerken, Kim12 (AUTHOR), Fu, Eric13 (AUTHOR), Solca, Flavio14 (AUTHOR), Lorence, Robert M.13 (AUTHOR), Ziegler, David S.15,16,17 (AUTHOR) |
| Source: | European Journal of Cancer. Jul2023, Vol. 188, p8-19. 12p. |
| Database: | Academic Search Ultimate |
Be the first to leave a comment!
